Il dolore orofacciale, ed Publiediting, 2020, Bibliografia

Bibliografia

Capitolo 1, La fisiopatologia del dolore

Chichorro JC, Porreca F, Sessle BJ, Mechanisms of craniofacial pain. Cephalalgia 2017; 37(7): 613-626.

Chiang CY, Dostrovsky JO, Iwata K et al. Role of glia in orofacial pain. Neuroscientist 2011; 17: 303-320.

Marchettini P. Manuale di Medicina del Dolore. Milano, Publiediting, 2016.

Nir RR, Yarnitsky D. Conditioned pain modulation. Curr Opin Support Palliat Care 2015; 9: 131-137.

Ossippov MH, Morimura K, Porreca F. Descending pain modulation and chronification of pain. Curr Opin Support Palliat Care 2014; 8: 143-151.

Ren K, Dubner R. The role of trigeminal interpolaris-caudalis transition zone in persistent orofacial pain. Int Rev Neurobiol 2011; 97: 207-225.

Siqueira SR, Alves B, Malpartida HM et al. Abnormal expression of voltage-gated sodium channels Nav 1.7, Nav 1.3 and Nav 1.8 in trigeminal neuralgia. Neuroscience 2009; 164: 573-577.

Sessle BJ, Peripheral and central mechanisms of orofacial inflammatory pain. Int Rev Neurobiol 2011; 97: 179-206.

Vachon-Presseau E, Centeno MV, Ren W et al. The emotional brain as a predictor and amplifier of chronic pain. J Dent Res 2016; 95: 695-612.

Youssef AM, Macefield VG, Henderson LA. Pain inhibits pain: human brainstem mechanisms. Neuroimage 2016; 124 (PtA): 54-62.

Capitolo 2, I test neurofisiologici per la valutazione del dolore orofacciale

Aramideh M, Ongerboer de Visser BW. Brainstem reflexes: electrodiagnostic techniques, physiology, normative data, and clinical applications. Muscle Nerve 2002; 26(1): 14-30.

Aramideh M, Ongerboer de Visser BW, Koelman JHTM et al. The late blink reflex abnormality due to lesions of the lateral tegmental field. Brain 1997; 120: 1685-1692.

Baad-Hansen L, List T, Jensen TS et al. Blink reflexes in patients with atypical odontalgia. J Orofac Pain 2005; 19: 239-247.

Baad-Hansen L, List T, Kaube H et al. Blink reflexes in patients with atypical odontalgia and matched healthy controls. Exp Brain Res 2006; 172: 498-506.

Costa YM, Baad-Hansen L, Bonjardim LR et al. Reliability of the nociceptive blink reflex evoked by electrical stimulation of the trigeminal nerve in humans. Clin Oral Investig. 2017; 21(8): 2453-2463.

Cruccu G, Sommer C, Anand P et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol 2010; 17: 1010-1018.

Cruccu G, Deuschl G. The clinical use of brainstem reflexes and hand-muscle reflexes. Clin Neurophysiol. 2000; 111(3): 371-87.

Cruccu G, Pauletti G, Agostino R et al. Masseter inhibitory reflex in movement disorders. Huntington's chorea, Parkinson's disease, dystonia, and unilateral masticatory spasm. Electroenceph clin Neurophysiol 1991; 81: 24-30.

De Tommaso M, Valeriani M, Guido M et al. Abnormal brain processing of cutaneous pain in patients with chronic migraine. Pain 2003; 101: 25-32.

Di Clemente L, Coppola G, Magis D et al. Interictal habituation deficit of the nociceptive blink reflex: an endophenotypic marker for presymptomatic migraine? Brain. 2007 Mar;130(Pt 3): 765-70. Epub 2007 Jan 24. PubMed PMID: 17251239.

Ellrich J, Bromm B, Hopf HC. Pain-evoked blink reflex. Muscle Nerve 1997 Mar;20(3): 265-70. PubMed PMID: 9052803.

Garcia-Larrea L, Peyron R, Laurent B, Mauguiere F. Association and dissociation between laser-evoked potentials and pain perception. Neuroreport 1997; 8: 3785-9.

Haanpää M, Attal N, Backonja M et al. NeuPSIG guidelines on neuropathic pain assessment. Pain 2011; 152(1): 14-27. doi: 10.1016/j.pain.2010.07.031.

Holle D, Zillessen S, Gaul C et al. Habituation of the nociceptive blink reflex in episodic and chronic cluster headache. Cephalalgia. 2012; 32(13): 998-1004.

Katsarava Z, Giffin N, Diener HC et al. Abnormal habituation of 'nociceptive' blink reflex in migraine evidence for increased excitability of trigeminal nociception. Cephalalgia 2003; 23(8): 814-819.

Kaube H, Katsarava Z, Kaufer T et al. A new method to increase nociception specificity of the human blink reflex. Clin Neurophysiol 2000; 111: 413-416.

Kaube H, Katsarava Z, Przywara S et al. Acute migraine headache: possible sensitization of neurons in the spinal trigeminal nucleus? Neurology 2002; 58: 1234-1238.

Kimura J, Lyon LW. Orbicularis oculi reflex in Wallenberg syndrome: alteration of the late reflex by lesion of the spinal tract and nucleus of the trigeminal nerve. J Neurol Neurosurg Psychiatry 1972; 35: 228-233.

Kumar S, Rastogi S, Kumar S et al. Pain in trigeminal neuralgia: neurophysiology and measurement: a comprehensive review. J Med Life 2013; 6(4): 383-388.

Lauria G, Holland N, Hauer P et al. Epidermal innervation: changes with aging, topographic location, and in sensory neuropathy. J Neurol Sci 1999; 164: 172-178.

Liang H. Imaging in Orofacial Pain. Dent Clin North Am. 2018 Oct; 62(4): 533-551. doi: 10.1016/ j.cden.2018.05.003.

McArthur JC, Stocks EA, Hauer P et al. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol 1998; 55: 1513-20.

Ongerboer de Visser BW. Anatomical and functional organization of reflexes involving the trigeminal system in man: jaw reflex, blink reflex, corneal reflex and exteroceptive suppression. Adv Neurol 1983; 39: 729-738.

Ongerboer de Visser BW, Cruccu G, Manfredi et al. Effects of brainstem lesions on the masseter inhibitory reflex. Functional mechanisms of reflex pathways. Brain 1990; 113: 781-792.

Ongerboer de Visser BW, Kuypers HGJM. Late blink reflex changes in lateral medullary lesions. An electrophysiological and neuroanatomical study of Wallenberg’s syndrome. Brain 1978; 101: 285-94.

Peddireddy A, Wang K, Svensson P et al. Blink reflexes in chronic tension-type headache patients and healthy controls. Clin Neurophysiol 2009; 120: 1711-1716.

Romaniello A, Valls-Sole J, Iannetti GD et al. Nociceptive quality of the laser-evoked blink reflex in humans. J Neurophysiol 2002; 87: 1386-1394.

Romaniello A, Iannetti GD, Truini A et al. Trigeminal responses to laser stimuli. Neurophysiol Clin 2003; 33(6): 315-324.

Romaniello A, Cruccu G, Frisardi G et al. Assessment of nociceptive trigeminal pathways by laser-evoked potentials and laser silent periods in patients with painful temporomandibular disorders. Pain 2003; 103: 31-39.

Shahani BT, Young RR. Human orbicularis oculi reflexes. Neurology 1972; 22: 149-154.

Treede RD, Lorenz J, Baumgärtner U. Clinical usefulness of laser-evoked potentials. Neurophysiol Clin. 2003; 33(6): 303-314.

Truini A, Haanpaa M, Zucchi R et al. Laser-evoked potentials in post-herpetic neuralgia. Clin Neurophysiol 2003; 114: 702-709.

Truini A, Padua L, Biasiotta A et al. Differential involvement of A-delta and A-beta fibres in neuropathic pain related to carpal tunnel syndrome. Pain 2009; 145: 105-109.

Valeriani M, Pazzaglia C, Cruccu G et al. Clinical usefulness of laser evoked potentials. Neurophysiol Clin 2012; 42(5): 345-53. doi: 10.1016/j.neucli.2012.05.002.

Valeriani M, De Tommaso M, Restuccia D et al. Reduced habituation to experimental pain in migraine patients: a CO2 laser evoked potential study. Pain 2003; 105: 57-64.

Capitolo 3, La visita del paziente con dolore orofacciale

Gilkey SJ, Plaza-Villegas F. Evaluation and management of orofacial pain. J of the Americ Acad of Phys Ass 2017; 30(5): 16-22.

Scrivani SJ, Spierings EL. Classification and differential diagnosis of oral and maxillofacial pain. Oral Maxillofac Surg Clin North Am 2016; 28(3): 233-246.

Capitolo 4, La psicodiagnosi nel dolore orofacciale: il valore della valutazione cognitivo-comportamentale

Abbate L. Testing psicologico e assessment diagnostico. La diagnosi in Psicologia clinica 2009.R. Cortina Editore 2009

Adamo D, Mignogna MD, Sardella A et al. 2013 I dolori Facciali: Sindrome della bocca che brucia (BMS)e dolore facciale idiopatico Persistente( PIFP). Dental Cadmos 6/2013

Bender SD (2014) Orofacial pain and headache: a review and look at the commonalities. Curr Pain Headache Rep Mar,18(3): 400

Benoliel R. et al (2019) The IASP Classification of chronic pain for ICD-11: Chronic Secondary headache or orofacial pain; PAIN JAN; 160(1):60-68

Brighina F, Cosentino G, Fierro B, Habituation or Lack of Habituation: what is really lacking in migraine?. Clin Neurophysiol 2016 127(1):19-20

Brighina F, Bolognini N, CosentinoG et al. Visual cortex hyperexcitability in migraine in response to sound-induced flash illusions Neurology. 2015 May 19;84(20):2057-61. doi: 10.1212/WNL.0000000000001584.

Buonfiglio M, Di Sabato F. .Analytic cognitive style in cluster headache Neurol Sci. 2011 Oct;32(5):875-81. doi: 10.1007/s10072-011-0730-1.

Buonfiglio M, Toscano M, Puledda F, Avanzini G,Di Clemente L,Di Piero V, Lack of habituation of evoked visual potentials in analytic information processing style: evidence in healthy subjects. Neurol sci 2015 36:391-95

Buonfiglio M, Di Sabato F, Mandillo S, Albini M, Di Bonaventura C, Giallonardo AT, Avanzini G. Analytic information processing style in epilepsy patients. Epilepsy &Behavior 73(2017)18-22

Buonfiglio M, Avanzini G, Brighina F. et al. Hyperresponsivity in migraine: a network dysfunction or an analytic cognive style–connected feature? Neurol Sci 40, 415–416 (2019). https://doi.org/10.1007/s10072-018-3593-x

Costa C. 2017 Persistent idiopathic facial pain (PIFP). Pathos 2017;24;3

Dazzi N. et al 2009 La Diagnosi in Psicologia Clinica, personalita’ e psicopatologia, R. Cotina Editore 2009

De Beni R., Moe’ A., Cornoldi C, AMOS Abilita’ e motivazione allo studio:prove di valutazione e orientamento. Trento Erikson 2003

Di Sabato F, Buonfiglio M, Mandillo S, Analytic information processing style in migraineurs. Neurol Sci 2013 34: 1145-1150

Facco E., Zanette G, Favero L et al 2008 il Dolore orofacciale: approccio terapeutico. Journal of dental anaesthesia vol 35( 1-2) :3- 28 (2008)

Graff- Radford SB, Abbott JJ, Temporomandibular disorders and headache 2016, Oromaxillofac Surg Clin North Am, Aug 28(3):2016

Pucci E, Segu M, Costa A, et al. (2010) Dolore oro-facciale: approccio terapeutico. Doctor Os 2010 gennaio 21 (1)

Riding R.J., Glass A.,Butler S. R, Pleydell-Pearce C. W, Cognitive style and individual differencs in EEG, Alfa during information processing. Educ Psychol 1997 17:2019-234

Sternberg R.J, Thinking Styles .Cambridge University Press 1997 Cambridge

Vicario G. B. Psicologia cognitivistica . Martello Giunti ,1976

Capitolo 5, La nevralgia trigeminale

Antonini G, Di Pasquale A, Cruccu G et al. MRI contribution for diagnosing symptomatic neurovascular contact in classic trigeminal neuralgia. A blinded case-control study and meta-analysis. Pain 2014; 155: 1464-1471.

Cruccu G, Finnerup N, Jensen TS et al. Trigeminal neuralgia: New classification and diagnostic grading for practice and research. Neurology 2016; 87: 220-228.

Cruccu G, Gronseth G, Alksne J et al. AAN-EFNS Guidelines in trigeminal neuralgia management. Eur J Neurol 2008; 15: 103-1028.

Devor M, Amir R, Rappaport ZH. Pathophysiology of trigeminal neuralgia: the ignition hypothesis. Clin J Pain 2002; 18: 4-13.

Fromm G. Pretrigeminal neuralgia. Neurology 1990; 40: 1493-1495.

Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629-808.

Maarbjerg S, Gozalov A, Olesen J et al. Concomitant persistent pain in classical trigeminal neuralgia - evidence for different subtypes. Headache 2014; 54: 1173-1183.

Maarbjerg S, Wolfram F, Gozalov A et al. Association between neurovascular contact and clinical characteristics in classical trigeminal neuralgia: A prospective clinical study using 3.0 Tesla MRI. Cephalalgia 2015; 35: 1077-1084.

Nomura T, Ikezaki K, Matsushima T et al. Trigeminal neuralgia: Differentiation between intracranial mass lesions and ordinary vascular compression as causative lesions. Neurosurg Rev 1994; 17: 51-57.

Peker S, Kurtkaya O, Uzun I et al. Micro anatomy of the central myelin-peripheral myelin transition zone of the trigeminal nerve. Neurosurgery 2006; 59: 354-359.

Younis S, Maarbjerg S, Reimer M et al. Quantitative sensory testing in classical trigeminal neuralgia- a blinded study in patients with and without concomitant persistent pain. Pain 2016; 157: 1407-1414.

Von Eckardstein KL, Keil M, Rohde V. Unnecessary dental procedures as a consequence of trigeminal neuralgia. Neurosurg Rev 2015; 38: 355-360.

Capitolo 6, La nevralgia glossofaringea

Blumenfeld A, Nikolskaya G. Glossopharyngeal neuralgia. Curr Pain Headache Rep 2013; 17(7):343.

Costa C. Le correnti a radiofrequenza applicate alla terapia del dolore. Publiediting, Milano 2017.

Katusic S, Williams DB, Beard CM et al. Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences . Rochester, Minnesota, 1945-1984. Neuroepidemiology 1991; 10 (5-6): 276-281.

Isamat F, Ferran E, Acebes JJ. Selective Percutaneous thermocoagulation rhizotomy in essential glossopharyngeal neuralgia. J Neurosurg 1981; 55 (4): 575-80.

Neerja Bharti, Suryabrata Chattopaddhyay, Navneet Singla et al. Pulsed radiofrequency ablation for the treatment of glossopharyngeal neuralgia secondary to oropharyngeal carcinoma. Pain Physician 2018; 21: 295-301.

Prencipe M. L’esame neurologico. Quadri normali e patologici. Piccin, Padova 2011.

Resnik DK, Jannetta PJ, Bissonnette D et al. Micro vascular decompression for glossopharyngeal neuralgia. Neurosurgery 1995 Jan; 36 (1): 64-8; discussion 68-69.

Rushton JG, Stevens JC, Miller RH. Glossopharyngeal (vago glossopharyngeal) neuralgia: a study of 217 cases. Arch Neurol 1981; 38 (4):201-205.

Samer N Narouze. Interventional management of head and face pain. Nerve blocks and beyond. Springer-Science 2014.

Singh PM, Kaur M, Trikha A. An uncommonly common: glossopharyngeal neuralgia. Ann Indian Acad Neurol 2013; 16 (1) :1-8.

Teixeira MJ, de Siqueira SR, Bor-Seng-Shu E. Glossopharyngeal neuralgia: neurosurgical treatment and differential diagnosis. Acta Neurochir (Wien) 2008; 150(5):471-475; discussion 475.

Williams BJ, Schlesinger D, Sheehan J. Glossopharyngeal neuralgia treated with gamma knife radiosurgery. World Neurosurg 2010; 73: 413-417.

Capitolo 7, La nevralgia occipitale

AAVV. Anatomia Umana. Fondamenti. Milano, Edi Ermes, 2018.

Kwon HJ, Kim HS, O J et al. Anatomical analysis of the distribution patterns of occipital cutaneous nerves and the clinical implications for pain management. J Pain Res 2018 Sep 25; 11: 2023-2031.

Cesmebasi A, Muhleman MA, Hulsberg P et al.Occipital neuralgia: anatomic considerations. Clin Anat 2015; 28(1): 101-108.

Choi I, Jeon SR. Neuralgias of the Head: Occipital Neuralgia. J Korean Med Sci 2016; 31(4): 479-488.

Cohen SP, Peterlin BL, Fulton L et al. Occipital neuralgia. Curr Pain Headache Rep 2014; 18(5): 411.

Riederer F, Sándor PS, Linnebank M et al. Familial occipital and nervus intermedius neuralgia in a Swiss family. J Headache Pain 2010 Aug; 11(4): 335-338.

Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition Cephalalgia 2013; 33(9): 629-808.

Kwon HJ, Kim HS, O J, Kang HJ et al. MDPulsed Radiofrequency for Occipital Neuralgia. Pain Physician 2014; 17: E709-E717.

Rodrigo D, Acin P, Bermejo P. Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness. Pain 2015; 156(12): 2585-94.

Capitolo 8, Il Dolore Facciale Idiopatico Persistente (PIFP)

Abrahamsen R, Baad-Hansen L, Svensson P. Hypnosis in the management of persistent idiopathic orofacial pain - clinical and psychosocial findings. Pain 2008; 136: 44-52.

Al Balawi S, Tariq M, Feinmann C. A double-blind, placebo-controlled, crossover, study to evaluate the efficacy of subcutaneous sumatriptan in the treatment of atypical facial pain. Int J Neurosci 1996; 86: 301-309.

Alonso-Blanco C, Fernandez-de-Las-Penas C, de-la-Llave-Rincon AI. Characteristics of referred muscle pain to the head from active trigger points in women with myofascial temporomandibular pain and fibromyalgia syndrome. J Headache Pain 2012; 13: 625-637.

Baad-Hansen L, List T, Kaube H. Blink reflexes in patients with atypical odontalgia and matched healthy controls. Exp Brain Res 2006; 172: 498-506.

Baad-Hansen L, Pigg M, Ivanovic SE. Chairside intraoral qualitative somatosensory testing: reliability and comparison between patients with atypical odontalgia and healthy controls. J Orofac Pain 2013; 27: 165-170.

Bahr A, Goadsby PJ. Diagnostic delays and mis-management in cluster headache. Acta Neurol Scand 2004; 109: 175-179.

Bayer E, Racz GB, Miles D. Sphenopalatine ganglion pulsed radiofrequency treatment in 30 patients suffering from chronic face and head pain. Pain Pract 2005; 5: 223-227.

Benoliel, R. Trigeminal autonomic cephalgias. Brit J Pain 2012; 6: 106-123.

Benoliel R, Birenboim R, Regev E. Neurosensory changes in the infraorbital nerve following zygomatic fractures. Oral Surg Oral Med Oral Path Oral Rad Endod 2005; 99: 657-665.

Benoliel, R, Eliav, E, Sharav, Y. Self-reports of pain-related awakenings in persistent orofacial pain patients. J Orofac Pain 2009; 23: 330-338.

Benoliel R, Birman N, Eliav E. The International Classification of Headache Disorders: accurate diagnosis of orofacial pain? Cephalalgia 2008; 28: 752-762.

Benoliel, R, Elishoov, H, Sharav, Y. Orofacial pain with vascular-type features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 84: 506-512.

Benoliel R, Zadik Y, Eliav E. Peripheral painful traumatic trigeminal neuropathy: clinical features in 91 cases and proposal of novel diagnostic criteria. J Orofac Pain 2012; 26: 49-58.

Campbell JK. Facial pain due to migraine and cluster headache. Semin Neurol 1988; 8: 324-331.

Cademartiri C, Torelli P, Cologno D. Upper and lower cluster headache: Clinical and pathogenetic observations in 608 patients. Headache 2002; 42: 630-637.

Cohen AS, Matharu MS, Goadsby PJ. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA) - a prospective clinical study of SUNCT and SUNA. Brain 2006; 129: 2746-2760.

Cady RK, Schreiber CP. Sinus headache: a clinical conundrum. Otolaryngol Clin North Am 2004; 37: 267-288.

Campbell RL, Parks KW, Dodds RN. Chronic facial pain associated with endodontic therapy. Oral Surg Oral Med Oral Pathol 1990; 69: 287-290.

Derbyshire SW, Jones AK, Devani P. Cerebral responses to pain in patients with atypical facial pain measured by positron emission tomography. J Neurol Neurosurg Psych 1994; 57: 1166-1172.

Eliav E, Gracely RH, Nahlieli O. Quantitative sensory testing in trigeminal nerve damage assessment. J Orofac Pain 2004; 18: 339-344.

Frazier C, Russell E. Neuralgia of the face: An analysis of 754 cases with relation to pain and other sensory phenomena before and after operation. Arch Neurol Psych 1924; 11: 557-563.

Forssell H, Tenovuo O, Silvoniemi P. Differences and similarities between atypical facial pain and trigeminal neuropathic pain. Neurology 2007; 69: 1451-1459.

Fromm GH, Graff-Radford SB, Terrence CF. Pre-trigeminal neuralgia. Neurology 1990; 40: 1493-1495.

Fernandez-de-Las-Penas C, Galan-Del-Rio F, Alonso-Blanco C. Referred pain from muscle trigger points in the masticatory and neck-shoulder musculature in women with temporomandibular disorders. J Pain 2010; 11: 1295-1304.

Galli U, Ettlin DA, Palla S. Do illness perceptions predict pain-related disability and mood in chronic orofacial pain patients? A 6-month follow-up study. Eur J Pain 2010; 14: 550-558.

Gaul C, Liesering-Latta E, Schafer B. Integrated multidisciplinary care of headache disorders: A narrative review. Cephalalgia 2016; 36: 1181-1191.

Harrison SD, Balawi SA, Feinmann C. Atypical facial pain: A double-blind placebo-controlled crossover pilot study of subcutaneous sumatriptan. Eur Neuropsychopharmacol 1997; 7: 83-88.

Hagelberg N, Forssell H, Aalto S. Altered dopamine D2 receptor binding in atypical facial pain. Pain 2003; 106: 43-48.

Headache Classification Subcommittee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd Edition (beta version). Cephalalgia 2013; 33: 629-808.

Hauser J, Hsu B, Nader ND. Inflammatory processes in complex regional pain syndromes. Immunol Invest 2013; 42: 263-272.

Heir GM, Nasri-Heir C, Thomas D. Complex regional pain syndrome following trigeminal nerve injury: Report of 2 cases. Oral Surg Oral Med Oral Path Oral Rad 2012; 114: 733-739.

Israel HA, Ward JD, Horrell B. Oral and maxillofacial surgery in patients with chronic orofacial pain. J Oral Maxillofac Surg 2003; 61: 662-667.

Jurgens TP, Muller P, Seedorf H. Occipital nerve block is effective in craniofacial neuralgias but not in idiopathic persistent facial pain. J Headache Pain 2012; 13: 199-213.

Jaaskelainen SK, Lindholm P, Valmunen T. Variation in the dopamine D2 receptor gene plays a key role in human pain and its modulation by transcranial magnetic stimulation. Pain 2014; 155: 2180-2187.

J Headache Pain 2012; 13: 625-637.

Klasser GD, Kugelmann AM, Villines D. The prevalence of persistent pain after nonsurgical root canal treatment. Quintessence Int 2011; 42: 259-269.

Koopman JS, Dieleman JP, Huygen FJ. Incidence of facial pain in the general population. Pain 2009; 147: 122-127.

Kuncz A, Voros E, Barzo P. Comparison of clinical symptoms and magnetic resonance angiographic (MRA) results in patients with trigeminal neuralgia and persistent idiopathic facial pain. Medium-term outcome after microvascular decompression of cases with positive MRA findings. Cephalalgia 2006; 26: 266-276.

Lang E, Naraghi R, Tanrikulu L. Neurovascular relationship at the trigeminal root entry zone in persistent idiopathic facial pain: findings from MRI 3D visualisation. J Neurol Neurosurg Psych 2005; 76: 1506-1509.

Lang UE, Kaltenhauser M, Seidler S. Persistent idiopathic facial pain exists independent of somatosensory input from the painful region: findings from quantitative sensory functions and somatotopy of the primary somatosensory cortex. Pain 2005; 118: 80-91.

Jaaskelainen SK, Forssell H, Tenovu O. Electrophysiological testing of the trigeminofacial system: Aid in the diagnosis of atypical facial pain. Pain 1999; 80: 191-200.

List T, Leijon G, Svensson P. Somatosensory abnormalities in atypical odontalgia: a case-control study. Pain 2008; 139: 333-341.

Mueller D, Obermann M, Yoon MS. Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: A population-based study. Cephalalgia 2011; 31: 1542-1548.

Mc, ET, Horton, BT. Atypical face pain; a statistical consideration of 66 cases. Ann Intern Med 1947; 27: 749-768.

Maarbjerg S, Gozalov A, Olesen J. Concomitant persistent pain in classical trigeminal neuralgia - evidence for different subtypes. Headache 2014; 54: 1173-1183.

Maarbjerg S, Wolfram F, Heinskou TB. Persistent idiopathic facial pain: a prospective systematic study of clinical characteristics and neuroanatomical findings at 3.0 Tesla MRI. Cephalalgia. Epub ahead of print 27 October 2016. doi: 10.1177/0333102416675618.

Maniam R, Kaye AD, Vadivelu N. Facial pain update: Advances in neurostimulation for the treatment of facial pain. Curr Pain Headache Rep 2016; 20: 24-24.

Marinus J, Moseley GL, Birklein F. Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol 2011; 10: 637-648.

Nobrega JC, Siqueira SR, Siqueira JT. Diferential diagnosis in atypical facial pain: A clinical study. Arq Neuropsiquiatr 2007; 65: 256-261.

Nurmikko TJ, Eldridge PR. Trigeminal neuralgia - pathophysiology, diagnosis and current treatment. Br J Anaesth 2001; 87: 117-132.

Nixdorf DR, Law AS, Lindquist K. Frequency, impact, and predictors of persistent pain after root canal treatment: a national dental PBRN study. Pain 2016; 157: 159-165.

Nguyen CT, Wang MB. Complementary and integrative treatments: atypical facial pain. Otolaryngol Clin North Am 2013; 46: 367-382.

Oaklander AL, Rissmiller JG, Gelman LB. Evidence of focal small-fiber axonal degeneration in complex regional pain syndrome-I (reflex sympathetic dystrophy). Pain 2006; 120: 235-243.

Oaklander AL, Fields HL. Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy? Ann Neurol 2009; 65: 629-638.

Penarrocha M, Bandres A, Penarrocha M. Lower-half facial migraine: a report of 11 cases. J Oral Maxillofac Surg 2004; 62: 1453-1456.

Prakash S, Rathore C, Makwana P. A cross-sectional clinic-based study in patients with side-locked unilateral headache and facial pain. Headache 2016; 56: 1183-1193.

Pigg M, Svensson P, Drangsholt M. Seven-year follow-up of patients diagnosed with atypical odontalgia: a prospective study. J Orofac Pain 2013; 27: 151-164.

Pareja JA, Cuadrado ML. SUNCT syndrome: An update. Expert Opin Pharmacother 2005; 6: 591-599.

Rushton JG, Gibilisco JA, Goldstein NP. Atypical face pain. J Am Med Assoc 1959; 171: 545-548.

Raskin NH. On the origin of head pain. Headache 1988; 28: 254-257.

Rahimpour S, Lad SP. Surgical options for atypical facial pain syndromes. Neurosurg Clin N Am 2016; 27: 365-370.

Rhodus NL, Fricton J, Carlson P. Oral symptoms associated with fibromyalgia syndrome. J Rheumatol 2003; 30: 1841-1845.

Renton T, Yilmaz Z. Profiling of patients presenting with posttraumatic neuropathy of the trigeminal nerve. J Orofac Pain 2011; 25: 333-344.

Schreiber CP, Hutchinson S, Webster CJ. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed “sinus” headache. Arch Intern Med 2004; 164: 1769-1772.

Schiffman E, Ohrbach R, Truelove E. Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and research applications: Recommendations of the International RDC/TMD.

Solomon S, Lipton RB. Atypical facial pain: a review. Semin Neurol 1988; 8: 332-338.

Sotorra-Figuerola D, Sanchez-Torres A, Valmaseda-Castellon E. Continuous neurophatic orofacial pain: a retrospective study of 23 cases. J Clin Exp Dent 2016; 8: e153-159.

Svensson P, Baad-Hansen L, Pigg M. Guidelines and recommendations for assessment of somatosensory function in oro-facial pain conditions - a task force report. J Oral Rehabil 2011; 38: 366-394.

Siqueira SR, Siviero M, Alvarez FK. Quantitative sensory testing in trigeminal traumatic neuropathic pain and persistent idiopathic facial pain. Arq Neuropsi 2013; 71: 174-179.

Stohler CS, Kowalski CJ, Lund JP. Muscle pain inhibits cutaneous touch perception. Pain 2001; 92: 327-333.

Svensson P, Bak J, Troest T. Spread and referral of experimental pain in different jaw muscles. J Orofac Pain 2003; 17: 214-223.

Sato J, Saitoh T, Notani K. Diagnostic significance of carbamazepine and trigger zones in trigeminal neuralgia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 97: 18-22.

Taiminen T, Kuusalo L, Lehtinen L. Psychiatric (axis I) and personality (axis II) disorders in patients with burning mouth syndrome or atypical facial pain. Scand J Pain 2011; 2: 155-160.

Won AS, Collins TA. Non-immersive, virtual reality mirror visual feedback for treatment of persistent idiopathic facial pain. Pain Med 2012; 13: 1257-1258.

Wirz S, Ellerkmann RK, Buecheler M. Management of chronic orofacial pain: a survey of general dentists in German university hospitals. Pain Med 2010; 11: 416-424.

Wright EF. Referred craniofacial pain patterns in patients with temporomandibular disorder. J Am Dent Assoc 2000; 131: 1307-1315.

Yoon MS, Mueller D, Hansen N. Prevalence of facial pain in migraine: A population-based study. Cephalalgia 2010; 30: 92-96.

Van Vliet JA, Eekers PJ, Haan J. Features involved in the diagnostic delay of cluster headache. J Neurol Neurosurg Psych 2003; 74: 1123-1125.

Viana M, Tassorelli C, Allena M. Diagnostic and therapeutic errors in trigeminal autonomic cephalalgias and hemicrania continua: a systematic review. J Headache Pain 2013; 14: 14-24.

Vickers ER, Cousins MJ. Neuropathic orofacial pain part 1 - prevalence and pathophysiology. Aust Endod J 2000; 26: 19-26.

Ziccardi VB, Dragoo J, Eliav E. Comparison of current perception threshold electrical testing to clinical sensory testing for lingual nerve injuries. J Oral Maxillofac Surgery 2012; 70: 289-294.

Zebenholzer K, Wober C, Vigl M. Facial pain in a neurological tertiary care centre: evaluation of the International Classification of Headache Disorders. Cephalalgia 2005; 25: 689-699.

Zakrzewska JM. Chronic/persistent idiopathic facial pain. Neurosurg Clin N Am 2016; 27: 345-351.

Capitolo 9, Il dolore neuropatico trigeminale post traumatico (PTTN, Post Traumatic Trigeminal Neuropathy)

Abrahamsen R, Baad-Hansen L and Svensson P. Hypnosis in the management of persistent idiopathic orofacial pain - clinical and psychosocial findings. Pain 2008; 136: 44-52.

Baad-Hansen L. Atypical odontalgia - pathophysiology and clinical management. J Oral Rehabil 2008; 35: 1-11.

Baad-Hansen L, Rafael Benoliel R. Neuropathic orofacial pain: facts and fiction. Cephalalgia 2017; 37(7): 670-679.

Benoliel R, Birenboim R, Regev E et al. Neurosensory changes in the infraorbital nerve following zygomatic fractures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99: 657-665.

Benoliel R, Eliav E, Elishoov H et al. Diagnosis and treatment of persistent pain after trauma to the head and neck. J Oral Maxillofac Surg 1994; 52: 1138-1147 (discussion 1147-1148).

Benoliel R, Zadik Y, Eliav E et al. Peripheral painful traumatic trigeminal neuropathy: clinical features in 91 cases and proposal of novel diagnostic criteria. J, Orofac Pain 2012; 26: 49-58.

Clark GT. Persistent orodental pain, atypical odontalgia, and phantom tooth pain: when are they neuropathic disorders? J Calif Dent Assoc 2006; 34: 599-609.

Di Stani F, Ojango C, Dugoni D et al. Combination of pharmacotherapy and lidocaine analgesic block of the peripheral trigeminal branches for trigeminal neuralgia: a pilot study. Arq Neuropsiquiatr. 2015 Aug;73(8): 660-664.

Di Stefano G, La Cesa S, Truini A et al. Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain. J Headache Pain 2014; 15: 34.

Eliav E and Benoliel R. Neuropathic orofacial pain mechanisms: Insights from human experimental studies. In: Sessle BJ (ed.) Orofacial pain: Recent advances in assessment, management, and understanding of mechanisms. Washington, DC: IASP Press, 2014, pp.415-434.

Finnerup NB and Jensen TS. Mechanisms of disease: mechanism-based classification of neuropathic pain - a critical analysis. Nat Clin Pract Neurol 2006; 2: 107-115.

Finnerup NB, Attal N, Haroutounian S et al. Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis. Lancet Neurol 2015; 14: 162-173.

Finnerup NB, Haroutounian S, Kamerman P et al. Neuropathic pain: an updated grading system for research and clinical practice. Pain 2016; 157: 1599-1606.

Finnerup NB, Otto M, McQuay HJ et al. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain 2005; 118: 289-305.

Haviv Y, Zadik Y, Sharav Y et al. Painful traumatic trigeminal neuropathy: An open study on the pharmacotherapeutic response to stepped treatment. J Oral Facial Pain Headache 2014; 28: 52-60.

Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629-808.

Jääskeläinen SK. Clinical neurophysiology and quantitative sensory testing in the investigation of orofacial pain and sensory function. J Orofac Pain 2004; 18: 85-107.

Jääskeläinen SK. Teerijoki-Oksa T and Forssell H. Neurophysiologic and quantitative sensory testing in the diagnosis of trigeminal neuropathy and neuropathic pain. Pain 2005; 117: 349-357.

Han SR, Yeo SP, Lee MK et al. Early dexamethasone relieves trigeminal neuropathic pain. J Dent Res 2010; 89: 915-920.

Maier C, Baron R, Tolle TR et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 2010; 150: 439-450.

Marbach JJ. Phantom tooth pain. Deafferentation pain. Pa Dent J 1984; 51: 32-33.

Matwychuk MJ. Diagnostic challenges of neuropathic tooth pain. J Can Dent Assoc 2004; 70: 542-546.

Nixdorf DR, Drangsholt MT, Ettlin DA et al. Classifying orofacial pains: A new proposal of taxonomy based on ontology. J Oral Rehabil 2012; 39: 161-169.

Nixdorf DR, Moana-Filho EJ, Law AS et al. Frequency of nonodontogenic pain after endodontic therapy: A systematic review and meta-analysis. J Endod 2010; 36: 1494-1498.

Penarrocha MA, Penarrocha D, Bagan JV et al. Post-traumatic trigeminal neuropathy. A study of 63 cases. Med Oral Patol Oral Cir Bucal 2012; 17: e297-300.

Piovesan EJ, Teive HG, Kowacs PA et al. An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology. 2005 Oct 25;65(8): 1306-8

Rafael B, Sorin T and Eli E. Painful traumatic trigeminal neuropathy. Oral Maxillofac Surg Clin North Am 2016; 28: 371-380.

Renton T and Yilmaz Z. Profiling of patients presenting with post-traumatic neuropathy of the trigeminal nerve. J Orofac Pain 2011; 25: 333-344.

Renton T and Yilmaz Z. Managing iatrogenic trigeminal nerve injury: a case series and review of the literature. Int J Oral Maxillofac Surg 2012; 41: 629-637.

Siqueira SR, Siviero M, Alvarez FK et al. Quantitative sensory testing in trigeminal traumatic neuropathic pain and persistent idiopathic facial pain. Arq Neuropsiquiatr 2013; 71: 174-179.

Smith JG, Elias LA, Yilmaz Z et al. The psychosocial and affective burden of posttraumatic neuropathy following injuries to the trigeminal nerve. J Orofac Pain 2013; 27: 293-303.

Svensson P, Baad-Hansen L, Pigg M et al. Guidelines and recommendations for assessment of somatosensory function in oro-facial pain conditions - a taskforce report. J Oral Rehabil 2011; 38: 366-394.

Treede RD, Jensen TS, Campbell JN et al. Neuropathic pain. Redefinition and a grading system for clinical and research purposes. Neurology 2008; 70: 1630-1635.

Treede RD, Rief W, Barke A et al. A classification of chronic pain for ICD-11. Pain 2015; 156: 1003-1007.

Woda A, Tubert-Jeannin S, Bouhassira D et al. Towards a new taxonomy of idiopathic orofacial pain. Pain 2005; 116: 396-406.

Woda A and Pionchon P. A unified concept of idiopathic orofacial pain: clinical features. J Orofac Pain 1999; 13: 172-184.

Capitolo 10, La sindrome delle bocca che brucia (BMS)

Azzi L, Croveri F, Pasina L et al. A burning therapy for burning mouth syndrome: preliminary results with the administration of topical capsaicin. J Biol Regul Homeost Agents 2017; 31 (2Suppl 1): 89-95.

Beneng K, Yilmaz Z, Yiangou Y et al. Sensory purinergic receptor P2X(3) is elevated in burning mouth syndrome. Int J Oral Maxillofac Surg 2010; 39(8):815-9. doi: 10.1016/j.ijom.2010.03.013. Epub 2010 Apr 24.

Coculescu EC, Radu A, Coculescu BI. Burning mouth syndrome: a review on diagnosis and treatment. J Med Life 2014; 7 (4): 512-515.

Coculescu EC, Tovaru S, Coculescu BI. Epidemiological and etiological aspects of burning mouth syndrome. J Med Life 2014; 15. 7 (3): 305-309.

DeMoraes M, do Amaral Bezerra BA, da Rocha Neto PC et al. Randomized trials for the treatment of burning mouth syndrome: an evidence-based review of the literature. J Oral Pathol Med 2012; Apr;41(4):281-7.

Forssell H, Jaaskelainen S, Tenovuo O et al. Sensory dysfunction in burning mouth syndrome. Pain. 2002 Sep. 99(1-2): 41-47.

Femiano F, Lanza A, Buonaiuto C et al. Burning mouth syndrome and burning mouth in hypothyroidism: proposal for a diagnostic and therapeutic protocol. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics 2008. 105: E22-27.

Feller L, Fourie J, Bouckaert M et al. Burning Mouth Syndrome: Aetiopathogenesis and Principles of Management Pain Res Manag 2017: 1926-69.

Kuten-Shorrer M, Treister NS, Stock S et al. Topical clonazepam solution for the management of burning mouth syndrome: a retrospective study. J Oral Facial Pain Headache 2017; 31 (3): 257-63.

Gurvits GE, Tan A. Burning mouth syndrome. World J Gastroenterol 2013; 19 (5): 665-72.

Galli F, Lodi G, Sardella A, Vegni E. Role of psychological factors in burning mouth syndrome: A systematic review and meta-analysis. Cephalalgia 2017; 37(3): 265-277.

Lauria G, Majorana A, Borgna M et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005; 115(3): 332-337.

Scala A, Checchi L, Montevecchi M et al. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 2003; 14(4): 275-291.

Lamey PJ, Lamb AB. Prospective study of aetiological factors in burning mouth syndrome. Br Med J (Clin Res Ed); 1988; 296 (6631): 1243-6.

Mo X, Zhang J, Fan Y et al. Thermal and mechanical quantitative sensory testing in Chinese patients with burning mouth syndrome: a probable neuropathic pain condition? J Headache Pain 2015; 16: 84.

Mínguez Serra MP, Salort Llorca C, Silvestre Donat FJ. Pharmacological treatment of burning mouth syndrome: A review and update. Med Oral Patol Oral Cir Bucal. 2007 Aug 1. 12(4): E299-304.

Miziara I, Chagury A, Vargas C, Freitas L, Mahmoud A. Therapeutic options in idiopathic burning mouth syndrome: literature review. Int Arch Otorhinolaryngol 2015; 19 (1): 86-89.

Moore PA, Guggenheimer J, Orchard T. Burning mouth syndrome and peripheral neuropathy in patients with type 1 diabetes mellitus. J Diabetes Complications. 2007; 21(6): 397-402.

Netto FO, Diniz IM, Grossmann SM et al. Risk factors in burning mouth syndrome: a case-control study based on patient records. Clin Oral Investig 2011; 15 (4): 571-5.

Svensson P, Kaaber S. General health factors and denture function in patients with burning mouth syndrome and matched control subjects. Journal of Oral Rehabilitation 1995; 22: 887-895.

Välimaa H, Savolainen S, Soukka T et al. Estrogen receptor-beta is the predominant estrogen receptor subtype in human oral epithelium and salivary glands. J Endocrinol 2004; 180(1): 55-62.

Capitolo 11, Herpes zoster e nevralgia posterpetica trigeminale

Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L et al. Quantification of risk factors for postherpetic neuralgia in herpes zoster patients. Neurology 2016; 87; 94-102.

Guo-wei L, Lan Qing, Zhang Wen-chuan. Clinical characteristics and treatment of trigeminal neuralgia following herpes zoster. Journal of craniofacial surgery 2015; 26(5) 448-451.

Hung CW, Wang SJ, Chen SP, Lirng JF et al. Trigeminal herpes zoster and Ramsay Hunt syndrome with a lesion in the spinal trigeminal nucleus and tract. J Neurol 2010; 257: 1045-1046.

Makharita MY, Amr YM, El Bayoumy Y. Effect of early stellate ganglion blockade for facial pain from acute herpes zoster and incidence of postherpetic neuralgia. Pain Physician 2012; 15: 467-474.

O’Neill F, Nurmikko T, Sommer C. Other facial neuralgias. Chephalalgia 2017; 37(7) 658-669.

Orlandini G. La semeiotica del dolore. 2ª ed, Antonio Delfino editore, 2014.

Reda H, Greene K, Rice FL, Rowbotham MC et al. Natural history of herpes zoster: late follow-up of 3.9 years (n=43) and 7.7 years (n=10). Pain 2013; 154: 2227-2233.

Thomas J, Liesegang MD. Herpes zoster ophthalmicus, natural history, risk factors, clinical presentation and morbidity. Ophthalmology 2008; 115, 2, supp February .

Truini A, Galeotti F, Haanpaa M, Zucchi R et al. Pathophysiology of pain in postherpetic neuralgia: a clinical and neurophysiological study. Pain 2008; 405-410.

Truini A, Haanpaa M, Provitera V, Biasiotta A et al. Differential myelinated and unmyelinated sensory and autonomic skin nerve fiber involvement in patients whit ophthalmic postherpetic neuralgia. Front Neuroanat 2015; 9:105.

Capitolo 12, Le algie facciali in età pediatrica

Bahgat D, Burchiel KJ et al. Trigeminal neuralgia in young adults. J Neurosurg 2011; 114: 1306-1311.

Grazzi L, Rigamonti A et al. Facial pain in children and adolescents. Neurol Sci 2005; 26: S101-S103.

Grazzi L, Rizzoli P et al. Atypical facial and head pain in childhood and adolescence. Current Pain and Headache Reports 2018; 22: 43.

Kondev L, Minster A. Headache and facial pain in children and adolescents. Orolaryngol Clin N Am 2003; 36: 1153-1170.

Madland G, Feinmann C. Chronic facial pain: a multidisciplinary problemi. J Neurol Neurosurg Psychiatry 2001; 71: 716-719.

Messina LM, Correnti E, Drago F et al. Indomethacin-responsive headaches in pediatric age: nosographic aspects and limitations on the use of indomethacin in pediatric population 2018; J Neurol Exp Neurosci 4(2): 36-41.

McAbee G. A review of episodic and chronic pediatric headache of brief duration. Pediatr Neurol 2015; 52: 137-42.

Raieli V, Eliseo G.L, Manfrè L et al. Trigeminal nevralgia and cerebellopontine-angle lipoma in a child: case report. Headache 2001; 41: 720-722.

Raieli V, Compagno A, Brighina F et al. Prevalence of red ear syndrome in juvenile primary headaches. Cephalalgia 2011; 31: 597-602.

Raieli V, Cicala V, Vanadia F. Pediatric paroxysmal hemicrania: a case report and some clinical considerations. Neurol Sci. 2015; 36(12): 2295-6.

Raieli V, Compagno A, D'Amelio M. Red Ear Syndrome. Curr Pain Headache Rep 2016; 20(3): 19.

Capitoli 13 e 14, Il dolore miogeno facciale e I disordini dell’ATM

Atsü SS, Güner S, Palulu N et al. Oral parafunctions, personality traits, anxiety and their association with signs and symptoms of temporomandibular disorders in the adolescents. African Health Sciences, 2019; 19(1); 1801- 1810.

Al-Khotani A, Naimi-Akbar A, Gjelset M, Albadawi E, Bello L, Hedenberg- Magnusson B et al. The associations between psychosocial aspects and TMD-pain related aspects in children and adolescents. J Headache Pain, 2016; 17: 30.

Barsky AJ, Peekna HM, Borus JF. Somatic symptom reporting in women and men. J Gen Intern Med 2001; 16: 266-275.

Carlson CR, Reid KI, Curran SL et al. Psychological and physiological parameters of masticatory muscle pain. Pain. 1998; 76: 297–307.

Dworkin SF, Huggins KH, LeResche L et al. Epidemiology of signs and symptoms in temporomandibular disorders: clinical signs in cases and controls. J Am Dent Assoc 1990; 120: 273-281.

Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord 1992; 6: 301-355.

Fischer L, Clemente JT, Tambeli CH. The protective role of testosterone in the development of temporomandibular joint pain. J Pain 2007; 8: 437-442.

Kalaykova S, Lobbezoo F, Naeije M. Effect of chewing upon disc reduction in the temporomandibular joint. J Orofac Pain 2011; 25 : 49?55.

Linton SJ, Bergbom S. Understanding the link between depression and pain. Scand J Pain 2011; 2:47-54.

McCreary CP, Clark GT, Merril RL et al. Psychological distress and diagnostic subgroups of temporomandibular disorder patients. Pain 1991; 44: 29-34.

Nilsson IM, Drangsholt M, List T. Impact of temporomandibular disorder pain in adolescents: differences by age and gender. J Orofac Pain 2009; 23(2): 115-122.

Nishiyama A, Kino K, Sugisaki M et al. Influence of psychosocial factors and habitual behavior in temporomandibular disorder-related symptoms in a working population in Japan. Open Dent J 2012; 6: 240-247.

Olivo SA, Bravo J, Magee DJ, Thie NM, Major PW, Flores-Mir C. The association between head and cervical posture and temporomandibular disorders: a systematic review. J Orofac Pain 2006; 20: 9-23.

Ohrbach R et al. Clinical orofacial characteristics associated with risk of first-onset TMD: the OPPERA prospective cohort study. Journal of Pain, 2014; 14, 33-50.

Peck CC, Goulet JP, Lobbezoo F et al. Expanding the taxonomy of the diagnostic criteria for temporomandibular disorders. Journal of Oral Rehabilitation 2014; 41(1): 2-23.

Ribeiro-Dasilva MC, Peres Line SR, dos Santos MCLG et al. Estrogen Receptor-? Polymorphisms and Predisposition to TMJ Disorder. Journal of Pain 2009; 10, 527-533.

Sangani D, Suzuki A, VonVille H et al. Gene mutations associated with temporomandibular joint disorders: a systematic review. OAlibJ 2015; 2(6): e1583.

Schiffman E, Ohrbach R, Truelove E et al. Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and research applications: recommendations of the international RDC/TMD consortium network and orofacial pain special interest group. Journal of Oral and Facial Pain and Headache 2014; 28(1): 6-27.

Smith SB, Maixner DW, Greenspan JD et al. Potential genetic risk factors for chronic TMD: genetic associations from the OPPERA Case Control Study. J Pain 2011; 12: T92?T101.

Svensson P. Muscle pain in the head: overlap between temporomandibular disorders and tension-type headaches. Curr Opin Neuro 2007; 20: 320-325.

Warren MP, Fried JL. Temporomandibular disorders and hormones in women. Cells Tissues Organs 2001; 169: 187-192.

Wieckiewicz M, Grychowska N, Wojciechowski K et al. Prevalence and correlation between TMD based on RDC/TMD diagnoses, oral parafunctions and psychoemotional stress in Polish university students. Biomed Res Int 2014; 47: 23-46.

Capitolo 15, La cefalea a grappolo

Ambrosini A, Vandenheed M et al. Suoccipital injection with a mixture of rapid and long-acting steroids in cluster headache: a double blind placebo-controlled study” Pain 2005; 118 (1-2); 92-6.

Afridi SK, Shields KG et al. Greater occipital nerve injection in primary headache syndromes-prolonged effects from a single injection. Pain 2006; 122 (1-2);126-9.

Abdel-Maskoud MB et al. Lithium treatment in cluster headache: review of literature. Eur J Psychiatry 2009 ; 23(1) 53-60.

Bacchelli E, Cainazzo MM et al. A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants. J Headache Pain 2016; 17(1): 114.

Bahra A, May A, Goadsby PJ. Cluster headache: a prospective clinical study with diagnostic implications. Neurology 2002; 12; 58(3): 354-61.

Baumber L et al. A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort. Neurology 2006; 66(12): 1888-93.

Burish M. Cluster Headache and Other Trigeminal Autonomic Cephalalgia. Neurology 2018; 24; 4: 1137-1156.

Burns B, Watkins L, Goadsby PJ. Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients. Lancet 2007; 369(9567): 1099-106.

Burns B,Watkins L, Goadsby PJ. Treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients. Neurology 2009;72(4): 341-5.

Brewer AC, Trentman TL, Ivancic MG et al. Long-term outcome in occipital nerve stimulation patients with medically intractable primary headache disorders. Neuromodulation 2013; 16(6): 557-62;

Bratbak DF, Nordgards, Stovner LJ et al. Pilot study of sphenopalatine injection of onabotulinumtoxin A for the treatment of intractable chronic migraine. Cephalalgia 2017; 37: 356-364.

Bussone G, Leone M. Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache 1990; 30: 411-417.

Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annual review of neuroscience 2001; 24: 487-517.

Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster headache: a randomized trial. JAMA 2009; 302 (22): 2451-2457.

Costa A, Pucci E, Antonaci F et al. The effect of intranasal cocaine and lidocaine on nitroglycerin induced attacks in cluster headache. Cephalalgia 2000; 20: 85-91.

Cohen AS, Matharu Ms, Goadsby PJ. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) of cranial autonomi features (SUNA): a prospective clinical study of SUNCT and SUNA. Brain 2006; 129 (pt10): 2746-2760.

Couch JRJ. Prednisone therapy for cluster headache. Headache 1978; 18: 219-221.

Fontaine D, Blond S, Lucas C et al. Occipital nerve stimulation improves the quality of life in medically-intractable chronic cluster headache: results of an observational prospective study. Cephalalgia 2017; 37 (12): 1173-9.

Gaul C, Diener HC, Silver N et al. Non-invasive vagus nerve stimulation for prevention and acute treatment of chronic cluster headache (PREVA): a randomised controlled study. Cephalalgia 2016; 36(6): 534-46.

Goadsby PJ. Trigeminal autonomic cephalalgia. Continuum Lifelong Learning Neurol 2012; 18(4); 883-895.

Huang L, Bocek M, Jordan JK. Memantine for the prevention of primary headache disorders. Annals of pharmacotherapy 2014; 48(11): 1507-11.

de Coo IF, Wilbrink LA, Haan J et al. Evaluation of the new ICHD-III beta cluster headache criteria. Cephalalgia 2016; 36: 547-51.

Hoffmann J, May A. Diagnosis, pathophysiology and management of cluster headache. Lancet Neurology 2017, 17:1.

Jürgens TP, Barloese M, May A et al. Long-term effectiveness of sphenopalatine ganglion stimulation for cluster headache. Cephalalgia. 2017; 37 (5): 423-34.

Ravishankar K. Classification of Trigeminal Autonomic Cephalalgia: What has Changed in International Classification of Headache Disorders-3 beta? Ann Indian Acad Neurol 2018; 21(Suppl 1): S45-S50.

Kumar U, Grant M. Somatostatin and somatostatin receptors. In Rehfeld Jf, Bundgaard Jr editors.

Leone M, Franzini A, Cecchini AP et al. Hypothalamic deep brain stimulation in the treatment of chronic cluster headache. Ther Adv Neurol Disord 2010;3: 187-95.

Leone M, Bussone G. Pathophysiology of trigeminal autonomic cephalalgias. Lancet Neurol 2009; 8(8) 755-764.

Leone M, D’amico D, Moschiano F et al. Melatonin versus placebo in the prophylaxis of cluster headache: a double blind pilot study with parallel groups. Cephalalgia 1996; 16(7)494-496.

LeoneM, Proietti Cecchini A, Messina G et al. Long-term occipital nerve stimulation for drug-resistant chronic cluster headache. Cephalalgia 2017; 37(8): 756-63.

Leroux E, Valade D et al. Suboccipital steroid injections for transitional treatment of patiens with more than two cluster headache attacks per day: a randomized, double-blind, placebo-controlled trial. The Lancet Neurology 2011; 10(10): 891-897.

Lambru G, Abu Bakar N et al. Greater occipital nerve blocks in chronic cluster headache: a prospective open label study. Eur J neurol. 2014; 21(2): 338-343.

Magis D, Allena M, Bolla M et al. Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study. Lancet Neurol 2007; 6(4): 314-321.

Manzoni GC, Taga A, Russo M, Torelli P. Age of onset of episodic and chronic cluster headache - a review of a large case series from a single headache centre. J Headache Pain 2016; 17: 44.

Matharu MS, Levy MJ. Subcutaneous octreotide in cluster headache: randomized placebo-controlled double blind crossover study. Ann Neurol 2004; 56(4): 488-94.

Mitsikostas et al. European headache federation consensus on technical investigation for primary headache disorders. The Journal of Headache and Pain 2016; 17: 5.

Weiner RL, Reed KL. Peripheral neurostimulation for control of intractable occipital neuralgia. Neuromodulation 1999;2(3): 217-221.

Obermann M, Holle D and Nagel S. Functional neuroimaging in trigeminal autonomic cephalalgias. Ann Indian Acad Neurol 2018; 21(Suppl 1): S51-S5.

Rehfeld J, Bundgaard JR. (Eds). Cellular peptide hormone synthesis and secretory pathways. Berlin, Heidelberg: Springer Berlin Heidelberg 2010. P.97-120.

Ruskell GL. Orbital passage of pterygopalatine ganglion efferents to paranasal sinues and nasal mucosa in man. Cells tissues organs 2003; 175: 223-228.

Rubio-Beltrán et al. PACAP38 and PAC1 receptor blockade: a new target for headache? The Journal of Headache and Pain 2018. 19: 64

Saper JR, Klapper J, Mathew NT et al. Intranasal civamide for the treatment of episodi cluster headache. Arch Neurol 2002; 59(6);990-4.

Scwedt TJ, Dodick DW et al. Occipital nerve stimulation for chronic cluster headache and hemicrania continua: pain relief and persistence of autonomic features. Cephalalgia 2006; 26 (8): 1025-7.

Shields Kg, Levy MJ, Goadsby PJ. Alopecia and cutaneous atrophy after greater occipital nerve infiltration with corticosteroid. Neurology 2004; 63(11): 2193-2194.

Trentman TL, Rosenfeld DM, Vargas BB et al. Greater occipital nerve stimulation via the Bion microstimulator: implantation technique and stimulation parameters. Clinical trial: NCT00205894. Pain physician 2009; 12(3): 621-8.

Ekbom K et al. Treatment of acute cluster headache with sumatriptan. The sumatriptan cluster headache study group. N Engl J Med 1991; 325(5): 322-326.

Torelli P, Manzoni GC. What predicts evolution from episodic to chronic cluster headache? Curr Pain Headache Rep 2002; 6(1): 65-70.

Tfelt-Hansen PC, Tfelt-Hansen J. Nitroglycerin headache and nitroglycerin-induced primary headaches from 1846 and onwards: A historical overview and an update. Headache 2009;49: 445-56.

VanderPluym J. Cluster headache: special consideration for treatment of female patients of reproductive age and pediatric patients. Curr Neurol Neurosci Rep 2016; 16(1): 5.

Vollesen L et al. Migraine and cluster headache: a common link. Journal Headache and Pain 2018; 19: 89.

Weiner RL, Reed RL. Peripheral neurostimulation for control of intractable occipital neuralgia. Neuromodulation 1999; Jul;2(3):217-21.

Yang FC, Chou KH, Kuo CY et al. The pathophysiology of episodic cluster headache: Insights from recent neuroimaging research. Cephalalgia 2018; 38(5): 970-983.

Tuka B, Szabó N, Tóth E et al. Release of PACAP-38 in episodic cluster headache patients - an exploratory study. The Journal of Headache and Pain 2016; 17(1): 69.

Waldenlind E, Gustafsson SA, Ekbom K et al. Circadian secretion of cortisol and melatonin in cluster headache during active cluster periods and remission. J Neurol Neurosurg Psychiatry 1987; 50: 207-13.

Wei DYT, Ong JJ and Goadsby PJ. Cluster Headache: Epidemiology, Pathophysiology, Clinical Features, and Diagnosis. Ann Indian Acad Neurol 2018; 21(Suppl 1): S3-S8.

Wei DYT & Jensen RH. Therapeutic approaches for the management of trigeminal autonomic cephalalgias. Neurotherapeutics 2018; 15: 346-360.

Yang Fc, Chou KH et al. The pathophysiology of episodic cluster headache: insight from recent neuroimaging research. Cephalalgia 2018; 38 (5): 970-983.

Capitolo 16, L'emicrania parossistica

Antonaci F, Sjaastad O. Chronic paroxysmal hemicrania (CPH): A review of the clinical manifestations. Headache 1989; 29: 648-56.

Boes CJ, Matharu MS, Goadsby PJ. The paroxysmal hemicrania-tic syndrome. Cephalalgia 2003; 23: 24-8.

Cittadini E, Matharu MS, Goadsby PJ. Paroxysmal hemicrania: A prospective clinical study of 31 cases. Brain 2008; 131: 1142-55.

Chinar Osman and Anish Bahra. Paroxysmal Hemicrania. Ann Indian Acad Neurol 2018; 21(Suppl 1): S16-S22.

Cohen AS, Goadsby PJ. Paroxysmal hemicrania responding to topiramate. J Neurol Neurosurg Psychiatry. 2007; 78: 96-7.

Evidence for trigemino-parasympathetic activation. Cephalalgia 1996; 16: 448-50.

Evers S, Husstedt IW. Alternatives in drug treatment of chronic paroxysmal hemicrania. Headache 1996; 36: 429-32.

Goadsby PJ, Edvinsson L. Neuropeptide changes in a case of chronic paroxysmal hemicranias: evidence for trigemino parasympathetic activation. Cephalalgia 1996; 16(6): 448-50.

Matharu MS, Cohen AS, Frackowiak RS, Goadsby PJ. Posterior hypothalamic activation in paroxysmal hemicrania. Ann Neurol 2006;59(3): 535-45.

Messina LM, Correnti E, Drago F et al. Indomethacin: responsive headaches in pediatric age: nosografic aspects and limitations on the use of indomethacin in pediatric population. J Neurol Exp Neurosci 4 (2): 36-41.

de Almeida DB, Cunali PA, Santos HL et al. Chronic paroxysmal hemicrania in early childhood: case report. Cephalalgia 2004; 24: 608-9.

Miller S, Lagrata S, Watkins L et al. Occipital nerve stimulation for medically refractory chronic paroxysmal hemicrania. Headache 2017;57(10): 1610-3.

Prakash S, Belani P, Susvirkar A et al. Paroxysmal hemicrania: A retrospective study of a consecutive series of 22 patients and a critical analysis of the diagnostic criteria. J Headache Pain 2013; 14: 26.

Pareja JA, Caminero AB, Franco E et al. Dose, efficacy and tolerability of long-term indomethacin treatment of chronic paroxysmal hemicrania and hemicrania continua. Cephalalgia 2001; 21: 906-10.

Porta-Etessam J, Cuadrado M, Rodríguez-Gómez O et al. Are cox-2 drugs the second line option in indomethacin responsive headaches? J Headache Pain 2010; 11: 405-7.

Rossi P, Di Lorenzo G, Faroni J et al. Seasonal, extratrigeminal, episodic paroxysmal hemicrania successfully treated with single suboccipital steroid injections. Eur J Neurol 2005; 12(11): 903-6.

Tso AR, Marin J, Goadsby PJ. Noninvasive vagus nerve stimulation for treatment of indomethacin-sensitive headaches. JAMA Neurology 2017; 74(10): 1266-7.

Walcott BP, Bamber NI, Anderson DE. Successful treatment of chronic paroxysmal hemicrania with posterior hypothalamic stimulation: Technical case report. Neurosurgery 2009; 65: E997.

Xanders LB, Ailani J. Diagnose and adios: Practical tips for the ongoing evaluation and care of TAC patients taking indomethacin. Curr Pain Headache Rep 2015; 19: 470.

Capitolo 17 - L'emicrania continua

Chowdhury D. Secondary (Symptomatic) Trigeminal Autonomic Cephalalgia. Ann Indian Acad Neurol 2018; 21(Suppl 1): S57-S69.

Evolution, Diagnosis,and Management. Ann Indian Acad Neurol 2018;21 (Suppl 1): S39-S44.

Mehta A, Chilakamarri P, Zubair A et al. Hemicrania Continua: a clinical perspective on diagnosis and management. Curr Neurol Neurosci Rep 2018; 18(12): 95.

Matharu MS, Goadsby PJ.Functional brain imaging in hemicrania continua: implications for nosology and pathophysiology. Curr Pain Headache Rep 2005; 9(4): 281-8.

Prakash S, Adroja B. Hemicrania Continua. Ann Indian Acad Neurol 2018; 21(Suppl 1): S23-S30.

Prakash S, Patel P. Hemicrania continua: clinical review, diagnosis and management. J Pain Res 2017; 10: 1493-1509.

Prakash S, Shah ND, Bhanvadia RJ. Hemicrania continua unresponsive or partially responsive to indomethacin: does it exist? A diagnostic and therapeutic dilemma. J Headache Pain 2009; 10(1): 59-63.

Peres MF, Valença MM, Gonçalves AL. Misdiagnosis of hemicrania continua. Expert Rev Neurother 2009; 9(9): 1371-8.

Ravishankar K. Classification of trigeminal autonomic cephalalgia: What has Changed in International Classification of Headache Disorders-3 Beta? Ann Indian Acad Neurol 2018; 21 (Suppl 1): S45-S50.

Obermann M, Holle D, Nagel S. Functional neuroimaging in trigeminal autonomic cephalalgias. Ann Indian Acad Neurol 2018; 21 (Suppl 1): S51-S56.

Wei DY, Yuan Ong JJ, Goadsby PJ. Overview of trigeminal autonomic cephalalgias: nosologic evolution, diagnosis, and management. Ann Indian Acad Neurol 2018; 21(Suppl 1): S39-S44

Viana M, Tassorelli C, Allena M et al. Diagnostic and therapeutic errors in trigeminal autonomic cephalalgias and hemicrania continua: a systematic review. J Headache Pain 2013; 14: 14.

Capitolo 18 - Le short-lasting unilateral neuralgiform headache attacks (SUNHA)

Arca KN, Singh HR SUNCT and SUNA: an Update and Review. Current Pain and Headache Reports 2018; 22: 56; doi.org/10.1007/s11916-018-0707-3.

Baraldi C, Pellesi L, Guerzoni S et al. Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal. J Headache Pain 2017;18 (1): 71. doi.org/ 10.1186/s10194-017-0777-3.

Barker F, Jannetta P, Bissonette D et al. The long-term outcome of microvascular decompression for trigeminal neuralgia. N Engl J Med 1996; 334: 1077-1083.

Barloese MCJ. The pathophysiology of the trigeminal autonomic cephalalgias, with clinical implications. Clin Auton Res 2018 Jun;28 (3): 315-324. doi: 10.1007/s10286-017-0468-9

Benoliel R, Sharav Y et al. Tic, Triggering, and Tearing: from CTN to SUNHA. Headache currents 2018; 997-1009.

Black DF, Dodick DW. Two cases of medically and surgically intractable SUNCT: A reason for caution and an argument for a central mechanism. Cephalalgia 2002; 22: 201-4.

Brian E. McGeeney. Cluster headache and other trigeminal autonomic cephalalgias. Semin Neurol 2018; 38: 603-607.

Chowdhury S Secondary (Symptomatic) Trigeminal Autonomic Cephalalgia. Ann Indian Acad Neurol 2018; 21(Suppl 1): S57-S69.

Cohen A. SUN: Short-Lasting Unilateral Neuralgiform Headache Attacks” Headache Currents 2017; 1010-1019.

Cohen AS, Matharu MS, Goadsby PJ. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA): A prospective clinical study of SUNCT and SUNA. Brain 2006; 129: 2746-60.

Wei DY & Jensen RH. Therapeutic approaches for the management of trigeminal autonomic cephalalgias. neurotherapeutics 2018; 15: 346-360.

Effendi K, Jarjoura S, Mathieu D. SUNCT syndrome successfully treated by gamma knife radiosurgery: case report. Cephalalgia 2011; 31: 870-3.

Eguia P, Garcia-Monco JC, Ruiz-Lavilla N et al. SUNCT and trigeminal neuralgia attributed to meningoencephalitis. J Headache Pain 2008; 9: 51-3.

Favoni V, Grimaldi D et al. SUNCT/SUNA and neurovascular compression: new cases and critical literature review. Cephalalgia 2013; 33 (16): 1337-48. doi: 10.1177/0333102413494273.

Graff-Radford SB. SUNCT syndrome responsive to gabapentin (Neurontin). Cephalalgia 2000; 20: 515-7.

Haviv Y, Khan J, Zini A et al. Trigeminal neuralgia (part I): revisiting the clinical phenotype. Cephalalgia 2016; 36: 730-746.

Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia 2018; 38 (1): 1-211.

Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version) Cephalalgia 2013; 33: 629-808.

Lambru G, Matharu MS. SUNCT, SUNA and trigeminal neuralgia: different disorders or variants of the same disorder? Curr Opin Neurol 2014; 27: 325-331.

Lambru G, Trimboli M, Tan S et al. Medullary infarction causing coexistent SUNCT and trigeminal neuralgia 2017; 37 (5): 486-490. doi: 10.1177/0333102416652093.

Leone M, Bussone G. Pathophysiology of trigeminal autonomic cephalalgias. Lancet Neurol 2009; 8: 755-64.

Leone M, Franzini A, D'Andrea G et al. Deep brain stimulation to relieve drug-resistant SUNCT. Ann Neurol 2005; 57 (6): 924-7. doi.org/10.1002/ana.20507.

Levy A and Matharu. MS Short-Lasting Unilateral Neuralgiform Headache Attacks. Ann Indian Acad Neurol 2018; 21 (1): S31-S38. doi: 10.4103/aian.AIAN_356_17: 10.4103/aian.AIAN_356_17

Maarbjerg S, Gozalov A, Olesen J et al. Trigeminal neuralgia - a prospective systematic study of clinical characteristics in 158 patients. Headache 2014; 54: 1574-1582.

Matharu M, May A. Functional and structural neuroimaging in trigeminal autonomic cephalalgias. Curr Pain Headache Rep 2008; 12: 132-137.

Matharu MS, Cohen AS, Boes CJ et al. Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing syndrome: A review. Curr Pain Headache Rep 2003; 7: 308-18.

Matharu MS, Cohen AS, Goadsby PJ. SUNCT syndrome responsive to intravenous lidocaine. Cephalalgia 2004; 24: 985-92.

May A and Goadsby PJ. The enigma of the interconnection of trigeminal pain and cranial autonomic symptoms. Cephalalgia 2016; 36: 727-729.

May A, Bahra A, Buchel C et al. Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing. Ann Neurol 1999; 46(5): 791-4.

McGeeney BH et al. Cluster headache and other trigeminal autonomic cephalalgias. Semin Neurol 2018; 38: 603-607.

Miller S, Watkins L, Matharu M. Long-term follow up of intractable chronic short lasting unilateral neuralgiform headache disorders treated with occipital nerve stimulation. Cephalalgia 2017; 38: 933-42. doi.org/10.1177/0333102417721716.

Montes E, Alberca R, Lozano P et al. SUNCT in two young women. Headache 2001; 41: 826-829.

Obermann M, Holle D, Nagel S. Functional neuroimaging in trigeminal autonomic cephalalgias. Ann Indian Acad Neurol 2018; 21(1): S51-S56.

Pareja JA, Alvarez M, Montojo T. SUNCT and SUNA: recognition and treatment. Curr Treat Options Neurol 2013; 15: 28-39.

Pareja JA, Cuadrado ML. SUNCT syndrome: An update. Expert Opin Pharmacother 2005; 6: 591-599.

Prakash KM, Lo YL. SUNCT syndrome in association with persistent horner syndrome in a Chinese patient. Headache 2004; 44: 256-8.

Putzki N, Nirkko A, Diener HC. Trigeminal autonomic cephalalgias: a case of post-traumatic SUNCT syndrome? Cephalalgia 2005; 25: 395-7.

Sékhara T, Pelc K, Mewasingh LD et al. Pediatric SUNCT syndrome. Pediatr Neurol 2005; 33: 206-7.

Sjaastad O, Bakketeig LS. Cluster headache prevalence. Vågå study of headache epidemiology. Cephalalgia 2003; 23: 528-33.

Sprenger T, Valet M, Platzer S et al. SUNCT: bilateral hypothalamic activation during headache attacks and resolving of symptoms after trigeminal decompression. Pain 2005; 113: 422-426.

Trauninger A, Alkonyi B, Kovács N et al. Methylprednisolone therapy for short-term prevention of SUNCT syndrome. Cephalalgia 2010; 30: 735-9.

Vikelis M, Xifaras M, Mitsikostas DD. SUNCT syndrome in the elderly. Cephalalgia 2005; 25: 1091-2.

Weng HY, Cohen AS. Phenotypic and treatment outcome data on SUNCT and SUNA, including a randomised placebo-controlled trial. Cephalalgia 2018; 38(9) 1554-1563

Williams MH, Broadley SA. SUNCT and SUNA: clinical features and medical treatment. J Clin Neurosci 2008; 15: 526-34.

Wober C. Tics in TACs: a step into an avalanche? Systematic literature review and conclusions. Headache 2017; 57(10): 1635-47. doi.org/10.1111/head.13099.

Yi- Ting Wei D et al. Overview of trigeminal autonomic cephalalgias: nosologic evolution, diagnosis, and management. Ann Indian Acad Neurol 2018; 21(Suppl 1): S39-S44. doi: 10.4103/aian.AIAN_348_17: 10.4103/aian.AIAN_348_17.

Capitolo 19, I blocchi nervosi periferici della faccia

Azman J, Cvetko E, Stopar T et al. A Novel Technique for Ultrasound-Guided Glossopharyngeal Nerve Block - A Proof of Concept Cadaver and Sonoanatomy Study. Conference: ESRA 2016.

Chen YJ, Chang PH, Chang KV et al. Ultrasound guide injection for medial and lateral pterygoid muscles: a novel treatment for orofacial pain. Medical Ultrasonography 2018; 1 (1): 115-116. doi: 10.11152/mu-1362.

Cok OY, Deniz S, Eker H et al. Management of isolated infraorbital neuralgia by ultrasound-guided infraorbital nerve block with combination of steroid and local anesthetic. Journal of Clinical Anesthesia 2017; 37: 146-148. doi: 10.1016/j.jclinane.2016.12.007.

Dach F, Éckeli ÁL, Ferreira K et al. Nerve Block for the Treatment of Headaches and Cranial Neuralgias - A Practical Approach. Headache: The Journal of Head and Face Pain 2015; 55, 59-71.doi: 10.1111/head.12516.

Eker HE, Cok OY, Aribogan A et al. Management of neuropathic pain with methylprednisolone at the site of nerve injury. Pain Med 2012; 13: 443-51.

Janis JE, Hatef DA, Ducic I et al. Anatomy of the auriculotemporal nerve: variations in its relationship to the superficial temporal artery and implications for the treatment of migraine headaches. Plastic and Reconstructive Surgery 2010; 125(5): 1422-1428 doi: 10.1097/prs.0b013e3181d4fb05.

Jeon Y, Kim S. Treatment of great auricular neuralgia with real-time ultrasound-guided great auricular nerve block. Medicine 2017; 96(12), e6325.doi: 10.1097/md.0000000000006325.

Kampitak W, Tansatit T, Shibata, Y. A Novel Technique of Ultrasound-Guided Selective Mandibular Nerve Block With a Lateral Pterygoid Plate Approach. Regional Anesthesia and Pain Medicine 2018; 1.doi: 10.1097/aap.0000000000000760.

Kampitak W, Tansatit T, Shibata Y. A Cadaveric Study of Ultrasound-Guided Maxillary Nerve Block Via the Pterygopalatine Fossa. Regional Anesthesia and Pain Medicine 2018; 43(6):625-630.doi: 10.1097/ aap.0000000000000790.

Nader A, Kendall MC, De Oliveria GS et al. Ultrasound-guided trigeminal nerve block via the pterygopalatine fossa: an effective treatment for trigeminal neuralgia and atypical facial pain. Pain Physician 2013;16 (5): E537-45.

Narouze SN. Glossopharyngeal Nerve Block. In: N. Narouze S (eds.) Interventional Management of Head and Face Pain. Springer 2014, New York, NY.

Takahashi H, Suzuki T. A modified anterior approach for ultrasound-guided maxillary nerve block and its application to the mandibular nerve block. Journal of Clinical Anesthesia 2018; 46:96-98.doi: 10.1016/j.jclinane.2018.01.015.

Thallaj A, Marhofer P, Moriggl B et al. Great auricular nerve blockade using high resolution ultrasound: a volunteer study. Anaesthesia 2010; 65(8): 836-840.doi: 10.1111/j.1365-2044.2010.06443.x.

Waldman SD. Auriculotemporal nerve block. In: Waldman SDm (ed). Atlas of interventional pain management. 4th ed. Philadelphia 2015; Saunders, an imprint of Elsevier Inc: 78-82.

Capitolo 20 - La tossina botulinica

Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 2005; 26: 785-793.

Aurora SK, Dodick DW, Turkel CC et al. On a botulinum toxin A for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 2010; 30(7): 793-803.57.

Blumenfeld AM, Schim JD, Chippendale TJ. Botulinum toxin Type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine. Headache 2008; 48(2): 210-20.Epub 2007 Nov 28.

Carosi G, Cauda R. Malattie Infettive. Mc Graw-Hill 2010.

Clark GT. Classification, causato and treatment of masticatory myogenous pain and dysfunction. Oral Maxillofac Sure Clin North Am 2008; 20: 145-157.

Comella CL, Jankovic J, Truong DD et al. Efficacy and safety of incobotulinumtoxina (nt 201, xeomin®), botulinum neurotoxin type A, without accessory proteins, in patients with cervical dystonia. J Neurol Sci 308: 103-109.

Costa J, Espirito-Santo C, Borges A et al. Botulinum toxin type a therapy for cervical dystonia. Cochrane Database Syst Rev 2005; 25 (1): CD003633.

Costa J, Espirito-Santo C, Borges A et al. Botulinum toxin type b for cervical dystonia. Cochrane Database Syst Rev 2005b; I, CD004315.

Clark GT. Classification, causation and treatment of masticatory myogenous pain and dysfunction. Oral Maxillofac Sure. Clin North Am 2008; 20, 145-157.

Denglehem C, Maes JM, Raoul G et al. Botulinum toxin A: analgesic treatment for temporomandibular Joint Disorders. Rev Stomatol Chir Maxillofac 2012; 113: 27-31.

Diener HC, Dodick DW, Aurora SK et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 2010; 30 (7): 804-814.

Dominguez C, Pozo-Rosich P, Torres-Ferrùs M et al. OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study. Our J Neurol 2018; (2): 411-416.

Dressler D et al. Antibody-induced failure of botulinum toxin a therapy in cosmetic indications. Dermatol Sure 2010; 36 (Suppl 4): 2182-7.

Eisele KH et al. Immunogenicity of NT201 (Xeomin 1) in cynomolgus monkeys following high-dose injections. Mov Discord 2008; 23 suppl 1: S15.

Glogau RG. Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes. Clin J Pain 2002; 18: S191-S197.

Guarda-Nardini L, Manfredini D, Salamone M et al. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Cranio 2008; 26, 126-135.

Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol 2000; 43: 249-259.

IHS. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; (24 suppl 1): 9-160.

Isturiz Re, Torres J, Besso J. Global distribution of infectious disease requiring intensive care. Crit Care Clin 2006; 22(3): 469-88.

Kamran Habib Awan. The Therapeutic usage of botulinum toxin (Botox) in non-cosmetic head and neck conditions. An evidence based review. Saudi Pharmaceutical Journal 2017; 25, 18-24.

Kurtoglu C, Gur O.H, Kurkcu M et al. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement. J Oral Maxillofac Surg 2008; 66, 1644-1651.

Mahant N, Clouston PD, Lorentz IT. The current use of botulinum toxin. J Clin Neurosci 2000; 7: 389-394.

Mathew NT, Jaffri SF. A double-bind comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine: a pilot study. Headache 2009;49 (10): 1466-78.

Naumann M, So Y, Argoff CE et al. Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the terapeutics and technology assessment subcommittee of the american academy of neurology. Neurology 2008; 70 (19): 1707-1714.

Moreau N et al. Topical review: potential use of botulinum toxin in the management of painful posttraumatic trigeminal neuropathy. J Oral and Facial Pain and Headache 2017; 31(1):7-18.

NIH Panel. Clinical use of botulinum toxin. NIH Consens Statement 1990 Nov 12-14; 8: 1-20.

Olesen J, Bousser MG, Diener HC et al. New Appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006; 26 (6): 742-746.

Rothrock JF. Botox-A for suppression of chronic migraine: commonly asked questions. Headache 2012; 52(4): 716-7.

Pellizzari R, Rossetto O, Schiavo G. Tetanusand botulinum neurotoxins: mechanism of action and therapeutic uses. The Royal Society, 1999.

Sobel J. Botulism Clin Infect Dis. 2005; 15;41(8):1167-1173.

Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. J Pediatric Ophthalmol and Strabismus 1980; 17: 21-25.

Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc 1981; 79: 734-770.

Scott AB, Rosenbaum A, Collins C.C. Pharmacologic Weakening of extra ocular muscles. Investing Ophthalmol 1973; 12: 924-927.

Von Lindern JJ, Niederhagen B, Berge S et al. Type a botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. J Oral Maxillofac Sure 2003; 61: 774-778.

Capitolo 21, Gli interventi sul ganglio di Gasser e sedi limitrofe

Bick SKB, Eskandar EN. Surgical treatment of trigeminal neuralgia. Neurosurg Clin N Am 2017; 28: 429-438.

Missios S, Mohammadi A, Barnett GH. Percutaneous treatment for trigeminal neuralgia. Neurosurg Clin N Am 2014; 25: 751-762.

Parmar M, Sharma N, Modgill V et al. Comparative evaluation of surgical procedures for trigeminal neuralgia. J Maxillofac Oral Surg 2013; 12 (4): 400-409.

Skirving DJ, Dan NG. A 20-year review of percutaneous balloon compression of the trigeminal ganglion. J Neurosurg 2001; 94: 913-917.

Tatlí M, Satici O, Kanpolat Y et al. Various surgical modalities for trigeminal neuralgia: literature study of respective long-term outcomes. Acta Neurochir 2008; 150: 243-255.

Wang JY, Bender MT, Bettegowda C. Percutaneous procedures for the treatment of trigeminal neuralgia. Neurosurg Clin N Am 2016; 27: 277-295.

Capitolo 22, Gli interventi sul ganglio sfenopalatino

Ashkenazi A, Levin M, Dodick DW. Peripheral procedures: nerve blocks, peripheral neurostimulation and botulinum neurotoxin injections. In: Silberstein SD, Lipton RB, Dodick DW (eds) Wolff’ Headache and Other Head Pain. New York: Oxford University Press; 2007: 767-792.

Bayer E, Racz GB, Miles D et al. Sphenopalatine ganglion pulsed radiofrequency treatment in 30 patients suffering from chronic face and head pain. Pain Pract 2005;5: 223-227.

Costa A, Pucci E, Antonaci F et al. The effect of intranasal cocaine and lidocaine on nitroglycerin- induced attacks in cluster headache. Cephalalgia 2000;20: 85-91.

Cady R, Saper J, Dexter K et al. A double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with tx360 (R) as acute treatment for chronic migraine. Headache. 2015; 55: 101-116.

Eagle W. Sphenopalatine neuralgia. Acta Otolaryngol 1942; 35: 66-84.

Gardner G, Gray A, O’Rahilly S. Anatomy: a regional study of human structure, 5th ed. Philadelphia, WB Saunders 1906; pp 676-677.

Hardebo J, Arbab M, Suzuki N et al. Pathways of parasympathetic and sensory cerebrovascular nerves in monkeys. Stroke 1991; 22: 331-342.

Khan S, Schoenen J, Ashina M. Sphenopalatine ganglion neuromodulation in migraine: what is

the rationale? Cephalalgia 2014; 34: 382-391.

Kudrow L, Kudrow DB, Sandweiss JH. Rapid and sustained relief of migraine attacks with intranasal lidocaine: preliminary findings. Headache 1995; 35: 79-82.

Kittrelle JP, Grouse DS, Seybold ME. Cluster headache. Local anaesthetic abortive agents. Arch Neurol 1985; 42: 496-498.

Maizels M, Scott B, Cohen W et al. Intranasal lidocaine for treatment of migraine: a randomized, double-blind, controlled trial. JAMA 1996; 276: 319-321.

Osborn AG. Radiology of the pterygoid plates and pterygopalatine fossa. AJR 1979; 132: 389-394.

Sanders M, Zuurmond WW. Efficacy of sphenopalatine ganglion blockade in 66 patients suffering from cluster headache: a 12- to 70-month follow-up evaluation. J Neurosurg 1997; 87: 876-880.

Schytz HW, Barlose M, Guo S et al. Experimental activation of the sphenopalatine ganglion provokes cluster-like attacks in humans. Cephalalgia 2013; 33: 831-841.

Schoenen J, Jensen RH, Lanteri-Minet M et al. Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study. Cephalalgia 2013; 33 (10): 816-830.

Tepper SJ, Stillman MJ. Cluster headache: potential options for medically refractory patients (when all else fails). Headache 2013; 53: 1183-1190.

Yang I Y, Oraee S. A novel approach to transnasal sphenopalatine ganglion injection. Pain Physician. 2006; 9: 131-134.

Waxman S. Correlative neuroanatomy, 23rd ed. Stamford, Appleton & Lange, 1996, pp 265-266.

Van Bets B, Raets I, Gypen E et al. Pulsed radiofrequency treatment of the pterygopalatine (sphenopalatine) ganglion in cluster headache: a 10 year retrospective analysis: 14AP7-5 (abstract). Eur J Anaesthesiol 2014;31: 233.

Capitolo 23, Gli interventi sul rachide cervicale per il dolore della testa e della faccia

Ambrosini A, Vandenheede M, Rossi P et al. Suboccipital injection with a mixture of rapid-and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain 2005; 118(1-2): 92-96.

Ashkenazi A, Young WB. The effects of greater occipital nerve block and trigger points injection on brush allodynia and pain in migraine. Headache 2005; 45(4): 350-354.

Bartsch T, Goadsby PJ. The trigemino cervical complex and migraine: current concepts and synthesis. Curr Pain Headache Rep 2003; 7 (5): 371-376.

Bovim G, Sand T. Cervicogenic Headache, migraine without aura and tension-type headache. Diagnostic blockade of greater occipital and supra-orbital nerves. Pain 1992; 51: 43-48.

Blumenfeld A, Ashkenazi A, Napchan U et al. Recommendations for the performance of peripheral nerve blocks for headaches-a consensus statement from the American Headache Society interventional procedures section. Headache 2013; 53: 437-446.

Knight YE, Goadsby PJ. The periaqueductal grey matter modulates trigeminovascular input: a role in migraine? Neuroscience 2001; 106(4): 793-800.

Kruit MC, Launer LJ, Overbosch J et al. Iron accumulation in deep brain nuclei in migraine. A population-based magnetic resonance imaging study. Cephalalgia 2009; 29 (3): 351-359.

Robertson BA, Morris ME. The role of cervical dysfunction in migraine: a systematic review. Cephalalgia 2008; 28(5): 474-483. doi: 10.1111/j.1468-2982.2008.01545.x.Epub 2008 Mar 3.

Schulman EA, Lake 3rd AE, Goadsby PJ et al. Defining refractory migraine and refractory chronic migraine: proposed criteria from Refractory Headache Special Interest Section of the American Headache Society. Headache 2008; 48(6): 778-82.

Silberstein S, Dodick D, Pearlman S. Defining the pharmacological intractable headache for clinical trials and clinical practice. Headache 2010; 50: 1499-506.

Capitolo 24, Le tecniche di neuromodulazione elettrica per il dolore della testa e della faccia

Bartsch T, Goadsby PJ. Central mechanisms of peripheral nerve stimulation in headache disorders. In: Slavin KV, editor. Peripheral nerve stimulation. Basel, Karger 2011; p. 203-209.

Brighina F, Palermo A, Daniele O et al. High-frequency transcranial magnetic stimulation on motor cortex of patients affected by migraine with aura: a way to restore normal cortical excitability? Cephalalgia 2010; 3: 46-52.

Cecchini AP, Mea E, Tullo V et al. Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data. Neurol Sci 2009; 30 (Suppl 1): S101-S104.

Ellrich J, Lamp S. Peripheral nerve stimulation inhibits nociceptive processing: an electrophysiological study in healthy volunteers. Neuromodulation 2005; 8: 225-232. doi: 10.1111/j.1525-1403.2005. 00029.x 27. Fitzgerald P, Fountain S, Daskalakis Z. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clinical Neurophysiology 2006; 117 (12): 2584-2596.

Hanai F. Effect of electrical stimulation of peripheral nerves on neuropathic pain. Spine (Phila Pa 1976). 2000; 25: 1886-92.

Keck ME, Welt T, Müller MB et al. Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacology 2002; 43: 101-109.

Krutsch JP, McCeney MH, Barolat G et al. A case report of subcutaneous peripheral nerve stimulation for the treatment of axial back pain associated with postlaminectomy syndrome. Neuromodulation 2008; 11: 112-115. doi: 10.1111/j.1525-1403.2008. 00151.x.

Lenaerts ME, Oommen KJ, Couch JR et al. Can vagus nerve stimulation help migraine? Cephalalgia 2008; 28: 392-395.

Lipton RB, Pearlman SH. Transcranial magnetic simulation in the treatment of migraine. Neurotherapeutics 2010;7: 204-212.

Macaca nemestrina: a c-fos immunocytochemical study. J Anat 1997; 190 (Pt 3): 367-375.

Hoffmann TJ, Simon BJ, Zhang Y et al. Low voltage vagal nerve stimulation reduces bronchoconstriction in guinea pigs through catecholamine release. Neuromodulation 2012; 15: 527-536.

Misra UK, Kalita J, Bhoi SK. High-rate repetitive transcranial magnetic stimulation in migraine prophylaxis: a randomized, placebo-controlled study. J Neurol 2013; 260: 2793-801.

Mørch CD, Nguyen GP, Wacnik PW et al. Mathematical model of nerve fiber activation during low back peripheral nerve field stimulation: analysis of electrode implant depth. Neuromodulation 2014; 17: 218-225. doi: 10.1111/ner.12163.

O’Neill CW, Liu JJ, Leibenberg E et al. Percutaneous plasma decompression alters cytokine expression in injured porcine intervertebral discs. Spine J 2004; 4: 88-98. doi: 10.1016/S1529- 9430(03)00423-6.

Reverberi C, Bonezzi C, Demartini L. Peripheral subcutaneous neurostimulation in the management of neuropathic pain: five case reports. Neuromodul 2009; 12: 146-155. doi: 10.1111/j.1525- 1403.2009.00201.x Silberstein SD, Mechtler LL, Kudrow DB et al. Non-invasive vagus nerve stimulation for the acute treatment of cluster headache: findings from the randomized, double-blind, sham-controlled ACT study. Headache 2016; 56: 1317-1332.

Trentman TL, Dodick DW, Zimmerman RS et al. Percutaneous occipital stimulator lead tip erosion: report of 2 cases. Pain Physician 2008; 11: 253- 256.

Trentman TL, Zimmerman RS. Occipital nerve stimulation: technical and surgical aspects of implantation. Headache 2008; 48: 319-327.

Vukovic Cvetkovic V, Jensen RH. Neurostimulation for the treatment of chronic migraine and cluster headache. Acta Neurol Scand 2019; 139 (1): 4-17. doi: 10.1111/ane.13034. Epub 2018 Oct 29.

Wall PD, SweetWH. Abolizione temporanea del dolore nell'uomo. Scienza 1967; 155 (3758): 108-109.

Weiner RL, Reed KL. Peripheral neurostimulation for control of intractable occipital neuralgia. Neuromodulation 1999; 2: 217-221.